Skip to content

Efficacy and safety of Qinghuagui decoction in conservative treatment of non-lactation mastitis: a randomized controlled clinical study

Efficacy and safety of Qinghuagui decoction in conservative treatment of non-lactation mastitis: a randomized controlled clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037375
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-lactation mastitis

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria of non-lactation mastitis in Western medicine; 2. Conform to the standard of TCM syndrome differentiation of phlegm-dampness and heat accumulation; 3. Female, 18-70 years old (including boundary value); 4. Patients have conservative treatment intention, informed consent, voluntary signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary hematopoietic diseases or endocrine diseases; 2. Patients with malignant tumors; 3. Those who are known to be allergic to the prescription composition of the test drug; 4. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
cure rate;cure time;Surgical proportion;

Secondary

MeasureTime frame
recurrence rate;time to recurrence;

Countries

China

Contacts

Public ContactFeng Jiamei

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

jessie_fjm@hotmail.com+86 13611708021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026